查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1954638

全球体外膜氧合（ECMO）设备市场：市场规模、占有率、成长率、依类型和应用划分的产业分析、区域洞察及未来预测（2026-2034）

Extracorporeal Membrane Oxygenation Machine Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 125 Pages | 商品交期: 请询问到货日

价格

体外膜氧合（ECMO）设备市场成长驱动因子

2025年全球体外膜氧合（ECMO）设备市场规模为5.528亿美元，预计2026年将成长至5.748亿美元。此外，预计在预测期（2026-2034年）内，该市场将以4.06%的复合年增长率成长，到2034年达到7.9005亿美元。

北美地区在全球ECMO设备市场中占领先地位，2025年市占率为49.36%，主要得益于该地区心血管疾病的高发生率。 手术数量不断增加，以及主要市场参与者的强大影响力。

体外膜氧合（ECMO）是一种先进的生命维持设备，可在体外为血液提供氧气和循环支持。它主要以两种模式运作：静脉-动脉（VA）模式和静脉-静脉（VV）模式。这项技术广泛应用于呼吸衰竭、急性呼吸窘迫症候群（ARDS）、肺栓塞、心因性休克、开胸手术併发症、重症 COVID-19 患者。

市场驱动因素

心血管和呼吸系统疾病的成长趋势

心血管疾病（CVD）和呼吸系统疾病负担的加重是推动 ECMO 设备需求的主要因素。在全球范围内，心血管疾病每年导致约 1860 万人死亡。 此外，急性呼吸窘迫症候群 (ARDS)、慢性阻塞性肺病 (COPD) 和呼吸衰竭的病例持续增加，对高阶生命维持系统的需求也随之增长。

美国每年报告约 19 万例 ARDS 病例。此外，全球每年约进行 4,600 例肺移植手术，其中约 80% 在北美和欧洲进行。这些因素显着推动了体外膜氧合 (ECMO) 设备市场的扩张。

技术进步

持续的技术创新，例如小型化氧合装置、先进的旋转泵、双腔插管、改进的迴路涂层和磁悬浮离心泵，正在改善患者的治疗效果。 现代体外膜氧合（ECMO）系统能够实现快速预充、降低血流阻力、减少血浆渗漏并最大限度减少併发症，因此在医院和重症监护室的应用日益广泛。

新冠疫情的影响

由于呼吸和循环支援设备的需求增加，新冠疫情对ECMO设备市场产生了正面影响。医院扩大了ECMO设施，以治疗新冠重症患者。主要製造商报告称，由于ECMO系统需求增加，疫情期间收入有所增长。

2020年和2021年使用量的激增加强了ECMO设备的全球部署，确立了其作为重症监护室关键基础设施的地位。

市场限制因子

儘管需求强劲，但ECMO系统的高昂成本限制了其在发展中国家的部署。 在美国，ECMO系统的价格在15.2万美元到17万美元之间；在印度，价格在3.5万美元到4.8万美元之间。包括耗材和专业人员在内的总治疗费用进一步加剧了负担能力的挑战，尤其是在低收入医疗体系中。

市场区隔分析

依类型

此市场细分分为静脉-动脉（VA）系统和静脉-静脉（VV）系统。

  • 静脉-动脉系统广泛应用于心臟支持和先天性心臟病病例，预计2025年将占最大的市场占有率，达到59.01%。
  • 由于呼吸衰竭病例数量的增加以及其在新冠肺炎（COVID-19）中的广泛应用，静脉-静脉系统预计将保持稳定增长。

依应用领域划分

市场区隔分为成人、儿童和新生儿。

  • 预计到 2026 年，成人市场将占主导地位，市占率达 76.46%，主要得益于成人心臟和呼吸系统疾病的高发生率。
  • 预计儿童市场将稳定成长，这主要归因于肺炎和先天性心臟病病例的增加。
  • 由于手术相关的併发症和风险因素，新生儿市场呈现温和成长。

区域洞察

北美

北美在先进的医疗保健基础设施和强大的製造商网路的支持下，预计将在 2025 年引领市场。 由于美国心血管疾病死亡率高，其持续推动区域成长。

欧洲

预计到2034年，欧洲将经历显着成长，这主要得益于有利的报销政策和研发投入的增加。

亚太地区

预计2026年至2034年，亚太地区的复合年增长率（CAGR）最高，这主要得益于体外膜氧合（ECMO）中心的扩张、庞大的患者群体以及中国、日本和印度医疗保健投资的增加。

拉丁美洲、中东和非洲

预计这些地区将经历适度增长，这主要得益于医疗保健基础设施的改善和先进医疗技术的日益普及。

北美仍将维持领先地位，2025年市占率将达到49.36%，但预计亚太地区在预测期内将实现最快成长。 儘管高昂的系统成本仍然是一个挑战，但持续的技术进步和不断扩大的医疗保健投资预计将维持市场长期扩张至2034年。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：主要发现

  • 主要国家的心臟和肺移植数量（2025年）
  • 新产品发布
  • 主要产业发展：重大併购与合作
  • COVID-19疫情的影响体外膜氧合（ECMO）设备市场

第五章 全球体外膜氧合（ECMO）设备市场分析、洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依类型划分
    • VA（静脉-动脉）ECMO设备
    • VV（静脉-静脉）ECMO设备
  • 市场分析、洞察与预测：依应用划分
    • 成人
    • 儿科
    • 新生儿
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东及非洲

第六章：北美体外膜氧合（ECMO）设备市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲体外膜氧合（ECMO）设备市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚
    • 其他欧洲地区

第八章 第九章：分析、洞察与预测亚太地区体外膜氧合（ECMO）设备市场（2021-2034）

  • 依国家划分
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳大利亚
    • 东南亚
    • 其他亚太地区

第九章：拉丁美洲体外膜氧合（ECMO）设备市场（2021-2034）分析、洞察与预测

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家
第十章：拉丁美洲体外膜氧合（ECMO）设备市场分析、洞察与预测中东和非洲（2021-2034）
  • 依国家划分
    • 海湾合作委员会 (GCC)
    • 南非
    • 其他中东和非洲国家/地区

第十一章 竞争分析

  • 全球市占率分析（2025）
  • 市场主要参与者概览（概述、产品、SWOT 分析、近期发展、策略、财务状况（基于现有资讯））
    • Getinge AB
    • LivaNova PLC
    • Xenios AG (Fresenius Medical Care)
    • EUROSETS
    • ABIOMED
    • Medtronic
    • NIPRO
    • Spectrum Medical
    • Terumo Corporation
Product Code: FBI100369

Growth Factors of extracorporeal membrane oxygenation (ECMO) machine Market

The global extracorporeal membrane oxygenation (ECMO) machine market was valued at USD 552.8 million in 2025 and is projected to grow to USD 574.8 million in 2026. The market is further expected to reach USD 790.05 million by 2034, exhibiting a CAGR of 4.06% during the forecast period (2026-2034).

North America dominated the global ECMO machine market with a 49.36% market share in 2025, driven by the high prevalence of cardiovascular diseases, rising number of surgical procedures, and strong presence of leading market players.

ECMO is an advanced life-support system used to oxygenate blood outside the body and provide circulatory support. It operates primarily in two modes: Veno-Arterial (VA) and Veno-Venous (VV). The technology is widely used in patients suffering from respiratory failure, acute respiratory distress syndrome (ARDS), pulmonary embolism, cardiogenic shock, open-heart surgery complications, and severe COVID-19 cases.

Market Drivers

Rising Prevalence of Cardiovascular and Respiratory Diseases

The growing burden of cardiovascular diseases (CVDs) and respiratory disorders is a major factor driving ECMO machine demand. Globally, cardiovascular diseases account for approximately 18.6 million deaths annually. Additionally, ARDS, chronic obstructive pulmonary disease (COPD), and respiratory failure cases continue to rise, increasing the need for advanced life-support systems.

In the U.S., around 190,000 ARDS cases are reported annually. Furthermore, nearly 4,600 lung transplant procedures are performed globally each year, with North America and Europe accounting for nearly 80% of the total. These factors significantly contribute to the expansion of the ECMO machine market.

Technological Advancements

Continuous innovations such as miniaturized oxygenators, advanced rotary pumps, dual-lumen cannula, improved circuit coatings, and magnetic levitation centrifugal pumps have enhanced patient outcomes. Modern ECMO systems offer rapid priming, lower blood flow resistance, reduced plasma leakage, and minimized complications, encouraging higher adoption across hospitals and critical care units.

COVID-19 Impact

The COVID-19 pandemic positively impacted the ECMO machine market due to increased demand for respiratory and circulatory support. Hospitals expanded ECMO capacity to treat critically ill COVID-19 patients. Major players reported revenue growth during the pandemic due to increased demand for ECMO systems.

The surge in usage during 2020 and 2021 strengthened the adoption of ECMO machines globally and established them as critical infrastructure in intensive care units.

Market Restraints

Despite strong demand, the high cost of ECMO systems limits adoption in developing economies. In the U.S., an ECMO system costs between USD 152,000 and USD 170,000, while in India, prices range from USD 35,000 to USD 48,000. The total procedural cost, including consumables and skilled personnel, further increases affordability challenges, especially in low-income healthcare systems.

Segmentation Analysis

By Type

The market is segmented into Veno-Arterial (VA) and Veno-Venous (VV) systems.

  • The Veno-Arterial segment held the largest share of 59.01% in 2025, owing to its extensive use in cardiac support and congenital heart defect cases.
  • The Veno-Venous segment is expected to grow steadily due to increasing respiratory failure cases and its widespread use during COVID-19.

By Application

The market is segmented into adult, pediatric, and neonatal.

  • The adult segment dominated with a 76.46% share in 2026, driven by high incidence of cardiac and respiratory disorders in adults.
  • The pediatric segment is expected to grow steadily due to rising pneumonia and congenital heart disease cases.
  • The neonatal segment shows moderate growth due to procedural complications and risk factors.

Regional Insights

North America

North America led the market in 2025, supported by advanced healthcare infrastructure and strong manufacturer presence. The U.S. continues to drive regional growth due to high cardiovascular mortality rates.

Europe

Europe is expected to grow at a substantial rate through 2034 due to favorable reimbursement policies and increased R&D investments.

Asia Pacific

Asia Pacific is projected to witness the highest CAGR during 2026-2034, supported by expanding ECMO centers, large patient pool, and growing healthcare investments in China, Japan, and India.

Latin America & Middle East & Africa

These regions are expected to grow at a moderate pace due to improving healthcare infrastructure and increasing adoption of advanced medical technologies.

Competitive Landscape

The ECMO machine market is consolidated, with major players including Getinge AB, Terumo Corporation, Medtronic plc, LivaNova PLC, Xenios AG, EUROSETS, ABIOMED, NIPRO, and Spectrum Medical.

Companies focus on product innovation, acquisitions, and regulatory approvals to strengthen their market position. Strategic developments and expansion of product portfolios are key competitive strategies.

Conclusion

The global ECMO machine market is set to grow steadily from USD 552.8 million in 2025 to USD 574.8 million in 2026, reaching USD 790.05 million by 2034, at a CAGR of 4.06%. Growth is primarily driven by the rising prevalence of cardiovascular and respiratory diseases, increasing adoption of advanced life-support technologies, and expanding ECMO centers worldwide.

North America remains the dominant region with a 49.36% share in 2025, while Asia Pacific is expected to register the fastest growth during the forecast period. Although high system costs pose a challenge, continuous technological advancements and growing healthcare investments are expected to sustain long-term market expansion through 2034.

Segmentation By Type, Application, and Region

By Type * Veno-Arterial

  • Veno-Venous

By Application

Adult

  • Pediatric
  • Neonatal

By Region * North America (By Type, By Application, By Country)

    • U.S.
    • Canada
  • Europe (By Type, By Application, By Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, By Application, By Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, By Application, By Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa (By Type, By Application, By Country/Sub-region)
    • South Africa
    • GCC
    • Rest of Middle East and Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Number of Heart and Lung Transplantations, By Key Countries, 2025
  • 4.2. New Product Launches
  • 4.3. Key Industry Developments - Key Mergers, Acquisitions and Partnerships
  • 4.4. Impact of COVID-19 on the Extracorporeal Membrane Oxygenation (ECMO) Machine Market

5. Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. VA (Veno-Arterial) ECMO Machine
    • 5.1.2. VV (Veno-Venous) ECMO Machine
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Adult
    • 5.2.2. Pediatric
    • 5.2.3. Neonatal
  • 5.3. Market Analysis, Insights and Forecast - By Geography
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. VA (Veno-Arterial) ECMO Machine
    • 6.1.2. VV (Veno-Venous) ECMO Machine
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Adult
    • 6.2.2. Pediatric
    • 6.2.3. Neonatal
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. VA (Veno-Arterial) ECMO Machine
    • 7.1.2. VV (Veno-Venous) ECMO Machine
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Adult
    • 7.2.2. Pediatric
    • 7.2.3. Neonatal
  • 7.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.3.1. U.K.
    • 7.3.2. Germany
    • 7.3.3. France
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Scandinavia
    • 7.3.7. Rest of Europe

8. Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. VA (Veno-Arterial) ECMO Machine
    • 8.1.2. VV (Veno-Venous) ECMO Machine
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Adult
    • 8.2.2. Pediatric
    • 8.2.3. Neonatal
  • 8.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. India
    • 8.3.4. South Korea
    • 8.3.5. Australia
    • 8.3.6. Southeast Asia
    • 8.3.7. Rest of Asia Pacific

9. Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. VA (Veno-Arterial) ECMO Machine
    • 9.1.2. VV (Veno-Venous) ECMO Machine
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Adult
    • 9.2.2. Pediatric
    • 9.2.3. Neonatal
  • 9.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Rest of Latin America

10. Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. VA (Veno-Arterial) ECMO Machine
    • 10.1.2. VV (Veno-Venous) ECMO Machine
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Adult
    • 10.2.2. Pediatric
    • 10.2.3. Neonatal
  • 10.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.3.1. GCC
    • 10.3.2. South Africa
    • 10.3.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Profiles of Players Operating in the Market (Overview, Products, SWOT Analysis, Recent Developments, Strategies, financials (based on availability))
    • 11.2.1. Getinge AB
      • 11.2.1.1. Overview,
      • 11.2.1.2. Products,
      • 11.2.1.3. SWOT Analysis,
      • 11.2.1.4. Recent Developments,
      • 11.2.1.5. Strategies,
      • 11.2.1.6. financials (based on availability)
    • 11.2.2. LivaNova PLC
      • 11.2.2.1. Overview,
      • 11.2.2.2. Products,
      • 11.2.2.3. SWOT Analysis,
      • 11.2.2.4. Recent Developments,
      • 11.2.2.5. Strategies,
      • 11.2.2.6. financials (based on availability)
    • 11.2.3. Xenios AG (Fresenius Medical Care)
      • 11.2.3.1. Overview,
      • 11.2.3.2. Products,
      • 11.2.3.3. SWOT Analysis,
      • 11.2.3.4. Recent Developments,
      • 11.2.3.5. Strategies,
      • 11.2.3.6. financials (based on availability)
    • 11.2.4. EUROSETS
      • 11.2.4.1. Overview,
      • 11.2.4.2. Products,
      • 11.2.4.3. SWOT Analysis,
      • 11.2.4.4. Recent Developments,
      • 11.2.4.5. Strategies,
      • 11.2.4.6. financials (based on availability)
    • 11.2.5. ABIOMED
      • 11.2.5.1. Overview,
      • 11.2.5.2. Products,
      • 11.2.5.3. SWOT Analysis,
      • 11.2.5.4. Recent Developments,
      • 11.2.5.5. Strategies,
      • 11.2.5.6. financials (based on availability)
    • 11.2.6. Medtronic
      • 11.2.6.1. Overview,
      • 11.2.6.2. Products,
      • 11.2.6.3. SWOT Analysis,
      • 11.2.6.4. Recent Developments,
      • 11.2.6.5. Strategies,
      • 11.2.6.6. financials (based on availability)
    • 11.2.7. NIPRO
      • 11.2.7.1. Overview,
      • 11.2.7.2. Products,
      • 11.2.7.3. SWOT Analysis,
      • 11.2.7.4. Recent Developments,
      • 11.2.7.5. Strategies,
      • 11.2.7.6. financials (based on availability)
    • 11.2.8. Spectrum Medical
      • 11.2.8.1. Overview,
      • 11.2.8.2. Products,
      • 11.2.8.3. SWOT Analysis,
      • 11.2.8.4. Recent Developments,
      • 11.2.8.5. Strategies,
      • 11.2.8.6. financials (based on availability)
    • 11.2.9. Terumo Corporation
      • 11.2.9.1. Overview,
      • 11.2.9.2. Products,
      • 11.2.9.3. SWOT Analysis,
      • 11.2.9.4. Recent Developments,
      • 11.2.9.5. Strategies,
      • 11.2.9.6. financials (based on availability)

List of Tables

  • Table 01: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 02: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Application, 2021-2034
  • Table 03: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Region, 2021-2034
  • Table 04: North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 05: North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Application, 2021-2034
  • Table 06: North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 07: North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Application, 2021-2034
  • Table 08: Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 09: Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Application, 2021-2034
  • Table 10: Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Country/Sub-region, 2021-2034
  • Table 11: Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 12: Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Application, 2021-2034
  • Table 13: Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Country/Sub-region, 2021-2034
  • Table 14: Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 15: Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Application, 2021-2034
  • Table 16: Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Country/Sub-region, 2021-2034
  • Table 17: Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 18: Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Application, 2021-2034
  • Table 19: Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue (USD million) Forecast, By Country, 2021-2034

List of Figures

  • Figure 01: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 02: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), By Type, 2025 & 2034
  • Figure 03: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Forecast (USD million), by VA ECMO, 2021-2034
  • Figure 04: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Forecast (USD million), by VV ECMO, 2021-2034
  • Figure 05: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), By Application, 2025 & 2034
  • Figure 06: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Forecast (USD million), by Pediatrics, 2021-2034
  • Figure 07: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Forecast (USD million), by Neonatal, 2021-2034
  • Figure 08: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Forecast (USD million), by Adults, 2021-2034
  • Figure 09: Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), By Region, 2025 & 2034
  • Figure 10: North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Type, 2025 & 2034
  • Figure 11: North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Type, 2025
  • Figure 12: North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Application, 2025 & 2034
  • Figure 13: North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Application, 2025
  • Figure 14: North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Country, 2025 & 2034
  • Figure 15: North America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Country, 2025
  • Figure 16: Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Type, 2025 & 2034
  • Figure 17: Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Type, 2025
  • Figure 18: Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Application, 2025 & 2034
  • Figure 19: Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Application, 2025
  • Figure 20: Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Country/Sub-region, 2025 & 2034
  • Figure 21: Europe Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Country/Sub-region, 2025
  • Figure 22: Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Type, 2025 & 2034
  • Figure 23: Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Type, 2025
  • Figure 24: Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Country/Sub-region, 2025 & 2034
  • Figure 27: Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Country/Sub-region, 2025
  • Figure 28: Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Type, 2025 & 2034
  • Figure 29: Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Type, 2025
  • Figure 30: Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Application, 2025 & 2034
  • Figure 31: Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Application, 2025
  • Figure 32: Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Country/Sub-region, 2025 & 2034
  • Figure 33: Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Country/Sub-region, 2025
  • Figure 34: Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Type, 2025 & 2034
  • Figure 35: Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Type, 2025
  • Figure 36: Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Application, 2025 & 2034
  • Figure 37: Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Application, 2025
  • Figure 38: Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value (USD million), by Country/Sub-region, 2025 & 2034
  • Figure 39: Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Machine Market Value Share (%), by Country/Sub-region, 2025
  • Figure 40: Global Extra Corporeal Membrane Oxygenation (ECMO) Machine Market Share (%), 2025